Opinion | Iโm the Prime Minister of Spain. This Is Why the West Needs Migrants.
'The regularization effort underway in Spain actually began as a citizen-led initiative endorsed by more than 900 nongovernmental organizations, including the Catholic Church, and it has the support of business associations and trade unions alike.'
www.nytimes.com/2026/02/04/o...
06.02.2026 15:07 โ ๐ 5 ๐ 6 ๐ฌ 0 ๐ 0
EZS European Zebrafish Society
The European Zebrafish Society was formed as a successor of "EuFishBioMed e.V." to foster zebrafish research, providing a platform for researchers and a framewokr for grant funding for young researche...
Congratulations to @ezsociety.bsky.social Christiane Nรผsslein-Volhard Award winner Liz Patton for her pioneering work with zebrafish models in melanoma research, outstanding scientific excellence, unwavering dedication to community service & shaping of learned societies ๐https://edin.ac/4r1an7d
05.02.2026 12:52 โ ๐ 7 ๐ 2 ๐ฌ 0 ๐ 0
RESEARCH PAPER: SOX2 phosphorylation during mitosis limits genomic damage
By Williams et al., and Steven Pollard
โก๏ธ https://genesdev.cshlp.org/content/40/3-4/185.full
Edinburgh University
#sox2 #chromatin #neural #mitosis #stemcells #phosphorylation
04.02.2026 19:00 โ ๐ 6 ๐ 3 ๐ฌ 0 ๐ 0
This is for you โ and a great opportunity โ if you are establishing a group in Croatia, Czechia, Estonia, Hungary, Lithuania, Luxembourg, Poland, Portugal and Tรผrkiye...
04.02.2026 08:42 โ ๐ 5 ๐ 8 ๐ฌ 0 ๐ 0
Ad for a postdoc position in centromere biology with colorful chromosomes and centromeres made out of FIMO.
๐งช My lab has an opening for a postdoc position soon! Please share/get in touch!
03.02.2026 13:59 โ ๐ 13 ๐ 17 ๐ฌ 0 ๐ 0
Today in @natgenet.nature.com, we report a saturation genome editing study that systematically dissects the degron of ฮฒ-Catenin, which contains 5 of the 25 most frequently mutated regions of the human cancer genome, and >70 recurrent missense mutations.
rdcu.be/e1Tvk
02.02.2026 16:10 โ ๐ 15 ๐ 5 ๐ฌ 3 ๐ 0
Congratulations Pradeep!
02.02.2026 20:07 โ ๐ 1 ๐ 0 ๐ฌ 1 ๐ 0
Check out our new findings showing BRD4's role in preventing the premature activation of developmental transcription factors via #Polycomb, providing new mechanistic insights into the pathogenesis of neurodevelopmental disorder #CdLS #NDDs, #chromatinopathies www.biorxiv.org/content/10.6...
02.02.2026 07:19 โ ๐ 35 ๐ 14 ๐ฌ 7 ๐ 1
An example of a voter suppression ad on Facebook. This ad was part of a Russian election interference campaign.
Exposure to voter suppression ads on Facebookโwhich targeted non-White residents of battleground statesโwas associated with a 1.9% decrease in voter turnout in the 2016 election, representing approximately 4.7 million fewer votes nationwide. In PNAS: https://ow.ly/HJGf50Y7FPG
02.02.2026 20:01 โ ๐ 10 ๐ 7 ๐ฌ 0 ๐ 1
๐ฃ I'm excited to share our latest preprint!
We adapt and characterise a neurosphere-based CNCC differentiation protocol, and demonstrate utility for quantitative phenotyping and craniofacial disease modelling! ๐งซ
Read about Array-CNCC here:
www.biorxiv.org/content/10.6...
@uoe-igc.bsky.social
28.01.2026 14:36 โ ๐ 46 ๐ 13 ๐ฌ 2 ๐ 1
SS18-SSX co-opts P300 to sustain oncogenic transcription independent of SWI/SNF activity
Synovial sarcoma is driven by the SS18-SSX fusion oncoprotein, which has been assumed to promote tumorigenesis through its incorporation into the SWI/SNF chromatin remodeling complexes. Accordingly, therapeutic efforts have focused on targeting SS18-SSX containing SWI/SNF assemblies, yet these approaches have produced limited clinical benefit. Here, we demonstrate that SS18-SSX sustains oncogenic transcription independent of SWI/SNF activity. Despite efficient degradation and dismantling of SWI/SNF complexes, fusion occupancy at target loci and associated gene expression programs remain largely intact. Instead, we identify the acetyltransferase P300 as an essential co-factor supporting SS18-SSX chromatin binding and transcriptional activation. Targeting P300 displaces the fusion from chromatin, suppresses its transcriptional output, compromising synovial sarcoma viability. Notably, dual PROTAC mediated degradation of P300 and SWI/SNF produces strong synergistic effects, broadly disrupting SS18-SSX localization and function. These findings redefine the mechanistic basis of synovial sarcoma and reveal a mechanistically anchored therapeutic strategy for targeting its core oncogenic driver. ### Competing Interest Statement C.R.V. has been a consultant for Flare Therapeutics, Roivant Sciences and C4 Therapeutics; has served on the advisory boards of KSQ Therapeutics, Syros Pharmaceuticals and Treeline Biosciences; has received research funding from Boehringer Ingelheim and Treeline Biosciences; and owns stock in Treeline Biosciences. S.A.A. has been a consultant and/or shareholder for Neomorph, Imago Biosciences, Hyku Therapeutics, C4 Therapeutics, Accent Therapeutics and Nimbus Therapeutics; and has received research support from Janssen and Syndax. N.O.C. is a co-founder, shareholder and management consultant for PhenoTherapeutics Ltd; and a shareholder in Amplia Therapeutics Ltd All other authors declare no financial interests UKRI, EP/X039633/1 Worldwide Cancer Research, https://ror.org/031tfbz57, 21-0271 Science Foundation Ireland, https://ror.org/0271asj38, 18/SIRG/5573
Synovial sarcoma is driven almost exclusively by a single oncofusion โ SS18-SSX
For years, the assumptions on disease mechanisms were simple:
โก๏ธ SS18-SSX works by hijacking SWI/SNF chromatin remodeling activity
Our new study shows that assumption was wrong ๐งต๐
www.biorxiv.org/content/10.6...
28.01.2026 09:54 โ ๐ 24 ๐ 10 ๐ฌ 2 ๐ 2
I did not know she was on Bluesky, but this whole work was led by @afroditisotiriou.bsky.social, a truly talented scientist that will finish her PhD this year and has not started looking for postdoc positions yet...
28.01.2026 10:36 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0
SS18-SSX co-opts P300 to sustain oncogenic transcription independent of SWI/SNF activity
Synovial sarcoma is driven by the SS18-SSX fusion oncoprotein, which has been assumed to promote tumorigenesis through its incorporation into the SWI/SNF chromatin remodeling complexes. Accordingly, therapeutic efforts have focused on targeting SS18-SSX containing SWI/SNF assemblies, yet these approaches have produced limited clinical benefit. Here, we demonstrate that SS18-SSX sustains oncogenic transcription independent of SWI/SNF activity. Despite efficient degradation and dismantling of SWI/SNF complexes, fusion occupancy at target loci and associated gene expression programs remain largely intact. Instead, we identify the acetyltransferase P300 as an essential co-factor supporting SS18-SSX chromatin binding and transcriptional activation. Targeting P300 displaces the fusion from chromatin, suppresses its transcriptional output, compromising synovial sarcoma viability. Notably, dual PROTAC mediated degradation of P300 and SWI/SNF produces strong synergistic effects, broadly disrupting SS18-SSX localization and function. These findings redefine the mechanistic basis of synovial sarcoma and reveal a mechanistically anchored therapeutic strategy for targeting its core oncogenic driver. ### Competing Interest Statement C.R.V. has been a consultant for Flare Therapeutics, Roivant Sciences and C4 Therapeutics; has served on the advisory boards of KSQ Therapeutics, Syros Pharmaceuticals and Treeline Biosciences; has received research funding from Boehringer Ingelheim and Treeline Biosciences; and owns stock in Treeline Biosciences. S.A.A. has been a consultant and/or shareholder for Neomorph, Imago Biosciences, Hyku Therapeutics, C4 Therapeutics, Accent Therapeutics and Nimbus Therapeutics; and has received research support from Janssen and Syndax. N.O.C. is a co-founder, shareholder and management consultant for PhenoTherapeutics Ltd; and a shareholder in Amplia Therapeutics Ltd All other authors declare no financial interests UKRI, EP/X039633/1 Worldwide Cancer Research, https://ror.org/031tfbz57, 21-0271 Science Foundation Ireland, https://ror.org/0271asj38, 18/SIRG/5573
Also very cool co-ordinated back-to-back with a sister preprint from colleagues (and office mate) @gerrybrien.bsky.social reporting the same finding ๐ค
www.biorxiv.org/content/10.6...
28.01.2026 10:21 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
SS18::SSX activates Polycomb target genes without BAF โ
Instead, transcription relies on EP300 via the SS18 QPGY domain
www.biorxiv.org/content/10.6...
โก๏ธ Coactivator targeting emerges as a new therapeutic strategy in synovial sarcoma ๐ฏ
Team work from @banitolab.bsky.social and @uoe-igc.bsky.social
28.01.2026 10:20 โ ๐ 22 ๐ 16 ๐ฌ 3 ๐ 0
Anyone know anything about Jennifer Harvey, who first isolated the virus containing HRAS (Harvey-Ras) at Mill Hill in 1967?
Prepping a lecture including the discovery of Ras oncogenes and wanted to add pics of the scientists involved.
The Internet has NOTHING
#sciencehistory #forgottenwomen
23.01.2026 10:17 โ ๐ 11 ๐ 10 ๐ฌ 9 ๐ 2
Very cool! Can't wait to see single-cell TimeVault ๐คฉ
23.01.2026 00:22 โ ๐ 3 ๐ 0 ๐ฌ 0 ๐ 0
Yes, this is where you would work (the round building, not the boat)
We are looking for a postdoc to join our team! If you're interested in translating a cutting edge genomics technology (www.nature.com/articles/s41...) to real-life applications in hematology, this is for you. We offer a unique working environment ON THE BEACH: recruitment.crg.eu/content/jobs...
20.11.2025 09:36 โ ๐ 17 ๐ 16 ๐ฌ 0 ๐ 3
EASTBIO - Dissecting CIC::DUX4 oncogenic circuitry through single-cell perturbation profiling and network inference at University of Edinburgh on FindAPhD.com
PhD Project - EASTBIO - Dissecting CIC::DUX4 oncogenic circuitry through single-cell perturbation profiling and network inference at University of Edinburgh, listed on FindAPhD.com
We have an exciting PhD opportunity through the EASTBIO programme, co-supervised with Diego Oyarzรบn. This project combines synthetic and systems biology to uncover the gene-regulatory circuitry hijacked in a cancer model. Weโre looking for candidates with a strong interest in functional genomics.
19.11.2025 13:15 โ ๐ 6 ๐ 2 ๐ฌ 0 ๐ 1
Why we made Affinity free, and how weโll keep it that way
Weโve made Affinity completely free, empowering professional designers with studio-grade creative software, supported by Canvaโs sustainable ecosystem.
I'm a longtime fan of Affinity Designer as an affordable Illustrator-killer for figures, and... it's now free?! www.canva.com/newsroom/new...
Highly recommended if you're sick of paying Adobe $. Maybe Canva can buy NPG too and get rid of the OA fees.
18.11.2025 23:28 โ ๐ 40 ๐ 10 ๐ฌ 1 ๐ 4
Job opportunity postodoctoral research fellow closing 18th November 2025
๐ฃJob Opportunity: Develop machine learning of cellular automata models with applications to in vitro developmental biology.
More info: edin.ac/49Mr7ZQ
12.11.2025 14:30 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 0
Congratulations @nsbenab.bsky.social and fellow experts joining the Independent Scientific Advisory Panel! ๐
@cmvm-edinburghuni.bsky.social
12.11.2025 15:16 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0
Beautiful (jaw-dropping ๐) work from Hannah Longโs group revealing how Neandertal enhancers influence facial morphology!
10.11.2025 11:42 โ ๐ 7 ๐ 0 ๐ฌ 0 ๐ 0
I guess I need to apologize to the writers of Alien: Prometheus. it turns out scientists really do touch everything like that
08.11.2025 16:30 โ ๐ 2665 ๐ 796 ๐ฌ 35 ๐ 26
๐ฅThis Wednesday , in #FragileNucleosome seminar, we are excited to host @hannahlong.bsky.social and @jeffvierstra.bsky.social to tell us about amazing work they are doing!
๐๏ธRegister here for upcoming session and the entire series:
us06web.zoom.us/webinar/regi...
03.11.2025 12:03 โ ๐ 20 ๐ 12 ๐ฌ 0 ๐ 0
Programmable promoter editing for precise control of transgene expression - @mitcheme.bsky.social @mitdeptofbe.bsky.social go.nature.com/4h9wlR1
13.10.2025 19:11 โ ๐ 21 ๐ 5 ๐ฌ 2 ๐ 0
๐ฆ Something HUGE just hatched.
Plasmidsaurus now offers RNA sequencing for gene expression analysis:
โข As fast as 3 day turnaround
โข $50/sample for academia, $80 for industry
โข Up to ~10M unique transcript 3โ end reads per sample
โข Interactive results
Explore Plasmidsaurus RNA-Seq today.
15.10.2025 16:02 โ ๐ 92 ๐ 36 ๐ฌ 4 ๐ 7
Computational Biologist in the Narita Lab, CRUK CI and CRA at Homerton College, University of Cambridge. ๐ฉท ๐๐โโฌ๐งถ๐งฎ๐ป๐งฌ๐งช๐งซ๐ญ
Senior post-doc in the Faulkner lab
ARC DECRA Fellow
Interested in how gene regulatory mechanisms contribute to biological complexity
Passionate scientist, runner, basket. Group leader at #IRBBarcelona | Targeted protein degradation | Chemical biology
MD, PhD | Medical Oncologist & Postdoctoral Researcher | AI & Computational Oncology | Sarcoma & Rare Cancers | Gustave Roussy & Heidelberg | Kung Fu practitioner | Philosophy lover |
Epigenetics enthusiast and MSCA fellow in Paola Scaffidi's lab @ IEO | Former postdoc in Emily Bernstein's lab @IcahnMountSinai | former @MSCActions PhD student in Maite Huarte's lab
PhD Fellow @DKFZ (German Cancer Research Center)
Cancer epigenetics, chromatin regulation, transcription.
Plastic and Reconstructive Surgery registrar, SCREDs post-doctoral clinical lecturer at the University of Edinburgh interested in face development and neural crest research
PhD student at Fraticelli lab @irbbarcelona.orgโฌ
I try to convert coffee into code and ideas for uncovering biological mysteries.
Some interests: single-cell, lineage tracing, computational biology, cellular variability, premalignancy, resistance...
Medical Oncologist at #RoyalMarsdenHospital - Soft tissue sarcoma - GIST - Desmoid tumour
Experimental and computational research group in regulatory, genome, and cancer evolution.
Currently (v2) at the DKFZ / Heidelberg University (2019-now)
Founded (v1) at the CRUK Cambridge Institute / University of Cambridge (2006-2022)
quantitative biology & frog enthusiast.
Group Leader at Institut Cochin, Paris, France
alumni UCBerkeley and Institut Curie
New PI @mpi_ie, interested epigenetics, development, homologous chromosome interactions and their function (she/her)
Curator of Herpetology & Associate Professor of Vertebrate Zoology at Natural History Museum of Denmark โข ERC StG: GEMINI โข Co-host of SquaMates Podcast and AnatomyInsights on Youtube โข He/Him
The leading charity dedicated to saving lives and fighting primary bone cancer through #Research, #Information, #Awareness and #Support. We are #TeamBones.
Whitehead Institute and Department of Biology, MIT. Lover of cell biology and cell division. Aspiring to do good science and do good.
๐งฌ Reviews Editor @biologists.bsky.social
๐ฉ๐ปโ๐ฌ PhD epigenetics & differentiation @uoe-igc.bsky.social
Views my own | she/her
The Banito Lab at the Hopp Children Cancer Center (KiTZ), German Cancer Research Center (DKFZ) in Heidelberg studies soft-tissue sarcomas - from underlying molecular mechanisms to development of new animal models.
Group leader @mpi-mg, Berlin
Chromatin tracing, epigenetics, development. Equity and advocacy in academia.